← FDA DRUG APPROVALS

FDA ANDA · ANDA070578

FUROSEMIDE

Sponsor: HOSPIRA

APPLICATION
ANDA070578
TYPE
ANDA
ORIGINAL APPROVAL
1987-07-08
LATEST ACTION
2001-02-14
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

FUROSEMIDEDiscontinued
FUROSEMIDE 10MG/ML · INJECTABLE · INJECTION

Approval history

2001-02-14Manufacturing (CMC) · Supplement 15AP
1998-10-01Manufacturing (CMC) · Supplement 14AP
1998-10-01Manufacturing (CMC) · Supplement 13AP
1997-08-12Labeling · Supplement 12AP
1995-12-22Manufacturing (CMC) · Supplement 11AP
1993-03-09Labeling · Supplement 8AP
1992-07-09Labeling · Supplement 6AP
1990-01-03Manufacturing (CMC) · Supplement 3AP
1990-01-03Manufacturing (CMC) · Supplement 4AP
1988-07-15Labeling · Supplement 2AP
1987-12-31Labeling · Supplement 1AP
1987-07-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →